Byrna Technologies Inc. reported robust financial results for the fourth quarter of 2024, surpassing revenue expectations with a 79% year-over-year increase to $28 million. The company's performance, ...

RedHill Biopharma Ltd (RDHL) reported its Q1 2022 earnings, revealing a decrease in net revenues to $18.2 million from $22.1 million in the previous quarter. Despite this, the company achieved a gross ...

Teva Pharmaceutical Industries Ltd. ADR-1.67% $19.87B ...

Morningstar analysts do not currently cover LTSAP, but with our powerful screener, you can find stocks in the same sector,industry, or style and filter on our unbiased ratings and valuation metrics.